Stay updated on Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial
Sign up to get notified when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.

Latest updates to the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page
- CheckyesterdayChange DetectedThe record no longer displays a 2018 U.S. NIH grant/contract reference, and the site revision indicator advances from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check8 days agoChange DetectedThe record continues to describe the completed Phase 1/2 study of pelabresib, with study details and results information displayed.SummaryDifference0.1%

- Check15 days agoChange DetectedThe record now displays details for the completed Phase 1/2 pelabresib study, including its arms, eligibility criteria, outcomes, results, and participating locations. It also includes study documents and information about sharing individual participant data.SummaryDifference100%

- Check22 days agoChange DetectedThe footer revision number changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check29 days agoChange DetectedA notification banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check36 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

Stay in the know with updates to Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.